KMO (gene) explained

Kynurenine 3-monooxygenase is an enzyme that in humans is encoded by the KMO gene.[1] [2]

Kynurenine 3-monooxygenase (KMO; EC 1.14.13.9) is an NADPH-dependent flavin monooxygenase that catalyzes the hydroxylation of the L-tryptophan metabolite L-kynurenine to form L-3-hydroxykynurenine.[supplied by OMIM][2] This is the first step in the degradation of Kyneurinine to Quinolinic acid. This pathway is involved in the activation of cytokine mediated changes in behavior due to inflammatory stimuli such as infections. The KMO gene is upregulated in the lung parenchyma of smokers. [3]

Further reading

Notes and References

  1. Alberati-Giani D, Cesura AM, Broger C, Warren WD, Rover S, Malherbe P . Cloning and functional expression of human kynurenine 3-monooxygenase . FEBS Lett . 410 . 2–3 . 407–12 . Sep 1997 . 9237672 . 10.1016/S0014-5793(97)00627-3 . 26490151 . free .
  2. Web site: Entrez Gene: KMO kynurenine 3-monooxygenase (kynurenine 3-hydroxylase).
  3. Pintarelli G, Noci S, Maspero D, Pettinicchio A, Dugo M, De Cecco L, Incarbone M, Tosi D, Santambrogio L, Dragani TA, Colombo F . Cigarette smoke alters the transcriptome of non-involved lung tissue in lung adenocarcinoma patients . Scientific Reports . 9 . 1 . 13039 . September 2019 . 31506599 . 6736939 . 10.1038/s41598-019-49648-2 . 2019NatSR...913039P .